Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia

Overview of attention for article published in Frontiers in Neurology, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 2 news outlets

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 17 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 10,265 followers.

New Research: Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia: Background: Cerebrospinal fluid (CSF) biomarkers are used to diagnose Alzheimer disease (AD), especially in atypical clinical presentations. No… https://t.co/

03 Jul 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.